Magnetic Resonance Imaging for Lung Cancer

Since the publication of the Radiologic Diagnostic Oncology Group Report in 1991, the clinical application of pulmonary magnetic resonance imaging (MRI) in patients with lung cancer has been limited. In contrast, MRI for lung cancer has undergone continuous development, and several promising techniques have been introduced to overcome the previously suggested limitations. In addition, comparative studies involving multidetector-row computed tomography and positron emission tomography or positron emission tomography/computed tomography with 2-deoxy-2-[18F]fluoro-D-glucose have shown useful new clinical applications for MRI in lung cancer. Moreover, MRI can provide not only morphologic information based on various parameters such as T1 and T2 relaxation times, tissue diffusion, perfusion, etc. but also functional information; it also has a significant role in nuclear medicine studies. In this review article, we describe recent advances made in MRI with respect to lung cancer, focusing on (1) detection of solid pulmonary nodules; (2) characterization of solid pulmonary nodules; (3) TNM staging assessment using chest and whole-body MRI examinations; (4) prediction of postsurgical lung function; and (5) prediction of tumor treatment response. We believe that further basic studies, as well as studies on clinical applications of new MRI techniques, are important for improving the management of lung cancer patients.

[1]  M. Decramer,et al.  Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  G. Adam,et al.  Detection of small pulmonary nodules in high-field MR at 3 T: evaluation of different pulse sequences using porcine lung explants , 2007, European Radiology.

[3]  N. Gupta,et al.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. , 2000, Chest.

[4]  Anne-Marie Sykes,et al.  CT screening for lung cancer: five-year prospective experience. , 2005, Radiology.

[5]  Y. Ohno,et al.  Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. , 2004, Radiology.

[6]  V. Lowe,et al.  Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. , 1995, Chest.

[7]  J. Austin,et al.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. , 2005, Radiology.

[8]  W. I. Tseng,et al.  Dynamic contrast‐enhanced MRI in advanced nonsmall‐cell lung cancer patients treated with first‐line bevacizumab, gemcitabine, and cisplatin , 2012, Journal of magnetic resonance imaging : JMRI.

[9]  Peter B Bach,et al.  Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[10]  K. Fujimoto,et al.  Aspergilloma within cavitary lung cancer: MR imaging findings. , 1994, AJR. American journal of roentgenology.

[11]  M. Kusumoto,et al.  Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma. , 1994, Investigative radiology.

[12]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[13]  W. Nishio,et al.  Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas , 2009, European Radiology.

[14]  C. Bolliger,et al.  Prediction of Functional Reserves after Lung Resection: Comparison between Quantitative Computed Tomography, Scintigraphy, and Anatomy , 2002, Respiration.

[15]  Wei Chen,et al.  Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? , 2010, Magnetic resonance imaging.

[16]  M. Haida,et al.  Lung cancer: differentiation of tumor, necrosis, and atelectasis by means of T1 and T2 values measured in vitro. , 1988, Radiology.

[17]  S. Sakai,et al.  Bronchogenic carcinoma invasion of the chest wall: evaluation with dynamic cine MRI during breathing. , 1997, Journal of computer assisted tomography.

[18]  Hyae-Young Kim,et al.  Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  N. Wu,et al.  Diffusion-weighted magnetic resonance imaging of lung cancer at 3.0 T: a preliminary study on monitoring diffusion changes during chemoradiation therapy. , 2012, Clinical imaging.

[20]  M. Gaeta,et al.  CT and MRI findings of mucin-containing tumors and pseudotumors of the thorax: pictorial review , 2002, European Radiology.

[21]  Geoffrey McLennan,et al.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging , 2010, Journal of magnetic resonance imaging : JMRI.

[22]  M Salerno,et al.  Dynamic spiral MRI of pulmonary gas flow using hyperpolarized 3He: Preliminary studies in healthy and diseased lungs , 2001, Magnetic resonance in medicine.

[23]  Y. Ohno,et al.  Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. , 2012, AJR. American journal of roentgenology.

[24]  J. Debatin,et al.  Whole-body MR imaging: evaluation of patients for metastases. , 2004, Radiology.

[25]  E H Moore,et al.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. , 1992, Radiology.

[26]  J. Biederer,et al.  Simulated pulmonary nodules implanted in a dedicated porcine chest phantom: sensitivity of MR imaging for detection. , 2003, Radiology.

[27]  L. Quint,et al.  Radiologic staging of lung cancer. , 1999, Journal of thoracic imaging.

[28]  Y. Ohno,et al.  STIR turbo SE MR imaging vs. coregistered FDG‐PET/CT: Quantitative and qualitative assessment of N‐stage in non‐small‐cell lung cancer patients , 2007, Journal of magnetic resonance imaging : JMRI.

[29]  Hiroto Hatabu,et al.  Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. , 2002, Radiology.

[30]  J. Choi,et al.  Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. , 2008, Radiology.

[31]  N. Gupta,et al.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small ( 3 cm) lymph node lesions. , 2000 .

[32]  Fritz Schick,et al.  Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. , 2006, Lung cancer.

[33]  Ning Wu,et al.  Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. , 2009, AJR. American journal of roentgenology.

[34]  S. Sone,et al.  Thin-rim enhancement in Gd-DTPA-enhanced magnetic resonance images of tuberculoma: a new finding of potential differential diagnostic importance. , 1992, Journal of thoracic imaging.

[35]  Y. Kitazume,et al.  Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? , 2008, AJR. American journal of roentgenology.

[36]  M. Schwaiger,et al.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Y. Ohno,et al.  Whole‐body MR imaging vs. FDG‐PET: Comparison of accuracy of M‐stage diagnosis for lung cancer patients , 2007, Journal of magnetic resonance imaging : JMRI.

[38]  E. Zerhouni,et al.  Interobserver Variability in CT and MR Staging of Lung Cancer , 1993, Journal of computer assisted tomography.

[39]  Y. Ohno,et al.  Dynamic MRI, dynamic multidetector‐row computed tomography (MDCT), and coregistered 2‐[fluorine‐18]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/CT: Comparative study of capability for management of pulmonary nodules , 2008, Journal of magnetic resonance imaging : JMRI.

[40]  S. Matsumoto,et al.  Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. , 2007, AJR. American journal of roentgenology.

[41]  Naofumi Hayabuchi,et al.  Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. , 2007, AJR. American journal of roentgenology.

[42]  F. Schick,et al.  Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions. , 2004, Radiology.

[43]  W. Oyen,et al.  Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer , 2007, Journal of Nuclear Medicine.

[44]  S. Matsumoto,et al.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.

[45]  Y. Liu,et al.  Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions , 2010, European Radiology.

[46]  J. Seo,et al.  3-T MRI: usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors. , 2007, AJR. American journal of roentgenology.

[47]  N. Konietzko.  Nuclear medicine techniques in the management of bronchogenic carcinoma , 2004, European Journal of Nuclear Medicine.

[48]  K Murata,et al.  Chest wall and mediastinal invasion by lung cancer: evaluation with multisection expiratory dynamic CT. , 1994, Radiology.

[49]  A. Golebiowski.  Pulmonary resection in patients over 70 years of age. , 1971, The Journal of thoracic and cardiovascular surgery.

[50]  M. Wahidi,et al.  Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[51]  K. Chida,et al.  Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. , 2009, Radiology.

[52]  S. Shiraishi,et al.  Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. , 2008, The Journal of thoracic and cardiovascular surgery.

[53]  Y. Ohno,et al.  Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects , 2008, European Radiology.

[54]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[55]  I. Freundlich,et al.  Magnetic resonance imaging of pulmonary apical tumors. , 1996, Journal of thoracic imaging.

[56]  M. Boers,et al.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial , 2002, The Lancet.

[57]  R. Hubner,et al.  Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma. , 2005, European journal of radiology.

[58]  M. Kanematsu,et al.  Prediction of Pulmonary Function After Resection of Primary Lung Cancer: Utility of Inhalation‐Perfusion SPECT Imaging , 1995, Clinical nuclear medicine.

[59]  Y. Ohno,et al.  Oxygen-enhanced MR imaging: correlation with postsurgical lung function in patients with lung cancer. , 2005, Radiology.

[60]  R Weissleder,et al.  Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[61]  G. Taplin,et al.  Lung imaging with radioaerosols for the assessment of airway disease. , 1980, Seminars in nuclear medicine.

[62]  H. Tonami,et al.  Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[63]  H. Bickel.  [Pulmonary function in bronchial carcinoma]. , 1959, Schweizerische medizinische Wochenschrift.

[64]  E. Butchart,et al.  Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours? , 1994, Thorax.

[65]  J. Debatin,et al.  Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. , 2005, AJR. American journal of roentgenology.

[66]  H. Shirato,et al.  Metastases in Mediastinal and Hilar Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Quantitative Assessment With Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient , 2010, Journal of computer assisted tomography.

[67]  M. Christian,et al.  [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.

[68]  J. Sedat,et al.  Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. , 1993, Radiology.

[69]  C. Ganter,et al.  MRI of the lung: Value of different turbo spin‐echo, single‐shot turbo spin‐echo, and 3D gradient‐echo pulse sequences for the detection of pulmonary metastases , 2007, Journal of magnetic resonance imaging : JMRI.

[70]  Y. Ohno,et al.  Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. , 2004, AJR. American journal of roentgenology.

[71]  J. Debatin,et al.  Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. , 2005, AJR. American journal of roentgenology.

[72]  John P Mugler,et al.  Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes--initial experience. , 2002, Radiology.

[73]  F. Wacker,et al.  MRI of the thorax during whole‐body MRI: Evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT) , 2008, Journal of magnetic resonance imaging : JMRI.

[74]  M. Kusumoto,et al.  Multiphase ECG‐triggered 3D contrast‐enhanced MR angiography: Utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma , 2001, Journal of magnetic resonance imaging : JMRI.

[75]  M. Chung,et al.  Solitary Pulmonary Nodule : Characterization with Combined Wash-in and Washout Features at Dynamic Multi – Detector Row CT 1 , 2005 .

[76]  S. Matsumoto,et al.  Prognostic value of dynamic MR imaging for non‐small‐cell lung cancer patients after chemoradiotherapy , 2005, Journal of magnetic resonance imaging : JMRI.

[77]  S. Shiraishi,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[78]  P. Molina,et al.  Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. , 1989, Radiology.

[79]  F. Forrer,et al.  Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography , 2012, European Radiology.

[80]  B J McNeil,et al.  CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. , 1991, Radiology.

[81]  S. Sone,et al.  MR of pulmonary hamartoma: pathologic correlation. , 1994, Journal of thoracic imaging.

[82]  H. Honda,et al.  Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. , 2011, Radiology.